Cargando…
Estimation of the Share of Net Expenditures on Insulin Captured by US Manufacturers, Wholesalers, Pharmacy Benefit Managers, Pharmacies, and Health Plans From 2014 to 2018
IMPORTANCE: Recent US media and policy attention on insulin affordability has focused on the role of manufacturers in setting prices; however, the role of other drug distribution intermediaries in determining prices has received less attention. OBJECTIVE: To estimate the share of net expenditures on...
Autores principales: | Van Nuys, Karen, Ribero, Rocio, Ryan, Martha, Sood, Neeraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796876/ https://www.ncbi.nlm.nih.gov/pubmed/35977268 http://dx.doi.org/10.1001/jamahealthforum.2021.3409 |
Ejemplares similares
-
Does the pharmacy expenditure of patients always correspond with their morbidity burden? Exploring new approaches in the interpretation of pharmacy expenditure
por: Calderón-Larrañaga, Amaia, et al.
Publicado: (2010) -
Acknowledgement to Reviewers of Pharmacy in 2014
Publicado: (2015) -
Panic buying or good adherence? Increased pharmacy purchases of drugs from wholesalers in the last week prior to Covid-19 lockdown
por: Kostev, Karel, et al.
Publicado: (2020) -
Issues affecting supply of palliative medicines into community pharmacy: A qualitative study of community pharmacist and pharmaceutical wholesaler/distributor perspectives
por: Campling, Natasha, et al.
Publicado: (2022) -
Acknowledgement to Reviewers of Pharmacy in 2018
Publicado: (2019)